可切除结直肠癌肝转移患者肝周淋巴结转移的预后影响
肝周淋巴结转移患者无复发生存和总生存均显著差于无转移者,且转移数目≥3个或位于肝十二指肠韧带者预后更差。原发肿瘤淋巴结转移和需再次肝切除的肝内复发是肝周淋巴结转移的独立危险因素。
要点
- 转移数目≥3个或位于肝十二指肠韧带者生存更差。
- 原发肿瘤淋巴结转移和需再次肝切除是危险因素。
核心结论
- 肝周淋巴结转移是可切除结直肠癌肝转移患者的不良预后因素,且转移数目和位置影响生存。
- 原发肿瘤淋巴结转移和需再次肝切除的肝内复发是肝周淋巴结转移的显著危险因素。
研究设计与样本
- 回顾性分析2003-2014年接受肝切除术的1485例结直肠癌肝转移患者,其中174例进行了淋巴结清扫。
临床怎么用
- 对具有原发肿瘤淋巴结转移或需再次肝切除等高危因素的患者,应考虑肝周淋巴结清扫以明确分期。
- 肝周淋巴结转移数目和位置可用于预后分层,指导术后随访和治疗决策。
局限性
- 本研究为回顾性分析,仅部分患者接受了淋巴结清扫,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although perihepatic lymph node metastases (PLNMs) are known to be a poor prognosticator for patients with colorectal liver metastases (CRLMs), optimal management remains unclear. This study aimed to determine the risk factors for PLNMs, and the survival impact of their number and location in patients with resectable CRLMs. METHODS: Data on patients with CRLM who underwent hepatectomy during 2003-2014 were analysed retrospectively. Recurrence-free (RFS) and overall (OS) survival were calculated according to presence, number and location of PLNMs. Risk factors for PLNM were evaluated by logistic regression analysis. RESULTS: Of 1485 patients, 174 underwent lymphadenectomy, and 54 (31·0 per cent) had PLNM. Ten patients (5·7 per cent) who had lymphadenectomy and 176 (13·4 per cent) who did not underwent repeat hepatectomy. Survival of patients with PLNM was significantly poorer than that of patients without (RFS: 5·3 versus 13·8 months, P < 0·001; OS: 20·5 versus 71·3 months; P < 0·001). Median OS was significantly better in patients with para-aortic versus hepatoduodenal ligament PLNMs (58·2 versus 15·5 months; P = 0·011). Patients with three or more PLNMs had significantly worse median OS than those with one or two (16·3 versus 25·4 months; P = 0·039). The presence of primary tumour lymph node metastases (odds ratio 2·35; P = 0·037) and intrahepatic recurrence requiring repeat hepatectomy (odds ratio 5·61; P = 0·012) were significant risk factors for PLNM on multivariable analysis. CONCLUSION: Patients undergoing repeat hepatectomy and those with primary tumour lymph node metastases are at significant risk of PLNM. Although PLNM is a poor prognostic factor independent of perihepatic lymph node station, patients with one or two PLNMs have a more favourable outcome than those with more PLNMs.
引用
- Okuno M, Goumard C, Mizuno T, et al. Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases. Br J Surg. 2018. PMID: 29664996. doi:10.1002/bjs.10822
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。